cycloserine has been researched along with Acute Post-Traumatic Stress Disorder in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (14.63) | 29.6817 |
| 2010's | 31 (75.61) | 24.3611 |
| 2020's | 4 (9.76) | 2.80 |
| Authors | Studies |
|---|---|
| Inslicht, SS; Lipshitz, SL; Marmar, CR; Metzler, TJ; Milad, MR; Neylan, TC; Niles, AN; Orr, SP; Otte, C | 1 |
| Cukor, J; Difede, J; Glatt, CE; Jovanovic, T; Lee, FS; Norrholm, SD; Olden, M; Reist, C; Rizzo, AA; Rothbaum, BO; Roy, MJ; Spielman, L; Wyka, K | 1 |
| Barth, J; Bavato, F; Dietrich, AC; Ehring, T; Kleim, B; Meister, L; Offenhammer, B; Rohde, J; Rosi-Andersen, A; Schäfer, I; Seifritz, E; Stefanovic, M | 1 |
| Difede, J; Glatt, C; Jovanovic, T; Lee, F; Norrholm, SD; Reist, C; Rizzo, AA; Rothbaum, BO; Roy, MJ; Spielman, L; Wyka, K | 1 |
| Daniels, WMU; de Souza, VBC; Hemmings, SMJ; Malan-Müller, S; Robinson, MD; Seedat, S | 1 |
| Daniels, WMU; Fairbairn, L; Gamieldien, J; Hart, S; Hemmings, SMJ; Jalali Sefid Dashti, M; Kidd, M; Malan-Müller, S; Seedat, S | 1 |
| Altemus, M; Cukor, J; Difede, J; Lee, FS; Olden, M; Peskin, M; Wyka, K | 1 |
| Abelson, JL; Floresco, SB; George, SA; Liberzon, I; Riley, J; Rodriguez-Santiago, M | 1 |
| Black, K; Koola, C; Norrholm, SD; Post, L; Rauch, SAM; Rothbaum, BO; Yasinski, C | 1 |
| Broekman, TG; de Kleine, RA; Hendriks, GJ; Smits, JA; van Minnen, A | 1 |
| Altemus, M; Cukor, J; Difede, J; Hoffman, H; Lee, FS; Olden, M; Wyka, K | 1 |
| Dodds, A; Rapp, A; Rynn, M; Walkup, JT | 1 |
| Scheeringa, MS; Weems, CF | 1 |
| Bradley, B; Davis, M; Duncan, EJ; Dunlop, B; Gerardi, M; Jovanovic, T; Norrholm, SD; Price, M; Ressler, KJ; Rizzo, A; Rothbaum, BO | 1 |
| Neylan, TC | 1 |
| Lewin, AB; McGuire, JF; Storch, EA | 1 |
| Beeské, S; Belzung, C; Griebel, G; Philbert, J | 1 |
| Bertoglio, LJ; Gazarini, L; Piornedo, RR; Stern, CA; Takahashi, RN | 1 |
| Heekin, M; Jovanovic, T; Maples, JL; Norrholm, SD; Price, M; Rothbaum, BO | 1 |
| Granoff, AL | 1 |
| Ressler, K; Rothbaum, BO | 1 |
| Smith, E | 1 |
| Price, M; Ressler, K; Rothbaum, BO | 1 |
| Lonak, SF; Marin, MF; Milad, MR | 1 |
| Becker, ES; de Kleine, RA; Hendriks, GJ; Smits, JA; van Minnen, A | 1 |
| Bradley, B; Breazeale, KG; Davis, M; Duncan, E; Gerardi, M; Jovanovic, T; Norrholm, SD; Price, M; Ressler, KJ; Rizzo, A; Rothbaum, BO; Tuerk, PW | 1 |
| McCracken, JT; McGuire, JF; Piacentini, J; Storch, EA; Wu, MS | 1 |
| Altemus, M; Cukor, J; Difede, J; Finkelstein-Fox, L; Lee, FS; Olden, M; Peskin, M; Rabinowitz, T; Wyka, K | 1 |
| Altemus, M; Anderson, P; Andersson, E; Cukor, J; Davis, M; de Kleine, RA; Difede, J; Dunlop, BW; Farrell, LJ; Fernández de la Cruz, L; Finck, C; Frumento, P; Geffken, GR; Geller, D; Gerardi, M; Golfels, F; Goodman, WK; Guastella, AJ; Gutner, C; Hendriks, GJ; Heyman, I; Hofmann, SG; Jovanovic, T; Kushner, MG; Lee, FS; Lenze, EJ; Levinson, CA; Lewin, AB; Mataix-Cols, D; McConnell, H; McNamara, JP; Monzani, B; Murphy, TK; Norrholm, S; Otto, MW; Pérez-Vigil, A; Plag, J; Pollack, MH; Ressler, KJ; Rodebaugh, TL; Rosenfield, D; Rothbaum, BO; Rück, C; Scheeringa, MS; Siewert-Siegmund, A; Smits, JAJ; Storch, EA; Ströhle, A; Tart, CD; Thuras, P; Tolin, DF; van Minnen, A; Waters, AM; Weems, CF; Wilhelm, S; Wyka, K | 1 |
| Michopoulos, V | 1 |
| McKay, D; Tryon, WW | 1 |
| Cukor, J; Difede, J; Rizzo, A; Rothbaum, BO; Spitalnick, J | 1 |
| Fuchikami, M; Liberzon, I; Matsuki, A; Morinobu, S; Takei, S; Yamamoto, S; Yamawaki, S | 1 |
| Choi, DC; Gerardi, M; Ressler, KJ; Rothbaum, BO | 1 |
| Broekman, TG; de Kleine, RA; Hendriks, GJ; Kusters, WJ; van Minnen, A | 1 |
| Adler, J | 1 |
| Krystal, JH | 1 |
| Bryant, RA; Hermos, JA; Hofmann, SG; Litz, BT; Otto, MW; Salters-Pedneault, K; Steenkamp, MM | 1 |
| Blanaru, M; Cohen, T; Goichman, R; Heresco-Levy, U; Javitt, DC; Kremer, I; Reshef, A | 1 |
| Bryant, RA | 1 |
| Fuchikami, M; Kozuru, T; Kurata, A; Morinobu, S; Yamamoto, S; Yamawaki, S | 1 |
11 review(s) available for cycloserine and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Pharmacological memory modulation to augment trauma-focused psychotherapy for PTSD: a systematic review of randomised controlled trials.
Topics: Cycloserine; Dexamethasone; Humans; Mifepristone; Propranolol; Psychotherapy; Randomized Controlled Trials as Topic; Stress Disorders, Post-Traumatic | 2023 |
Treatment of pediatric anxiety disorders.
Topics: Adolescent; Anticonvulsants; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Phobic Disorders; Riluzole; Stress Disorders, Post-Traumatic | 2013 |
Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.
Topics: Animals; Anxiety Disorders; Behavior Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Stress Disorders, Post-Traumatic; Yohimbine | 2014 |
Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety Disorders; Cycloserine; Endocannabinoids; Estrogens; Evidence-Based Medicine; Histone Deacetylase Inhibitors; Humans; Methylene Blue; Nootropic Agents; Psychotherapy; Stress Disorders, Post-Traumatic | 2015 |
A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Child; Combined Modality Therapy; Cycloserine; Female; Humans; Implosive Therapy; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Randomized Controlled Trials as Topic; Stress Disorders, Post-Traumatic; Treatment Outcome; Young Adult | 2017 |
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
Topics: Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Drug Synergism; Excitatory Amino Acid Agonists; Humans; Implosive Therapy; N-Methylaspartate; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Stress Disorders, Post-Traumatic | 2017 |
Memory modification as an outcome variable in anxiety disorder treatment.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Learning; Memory Disorders; Obsessive-Compulsive Disorder; Stress Disorders, Post-Traumatic; Treatment Outcome | 2009 |
Emerging treatments for PTSD.
Topics: Cognitive Behavioral Therapy; Combat Disorders; Computer Simulation; Cycloserine; Humans; Implosive Therapy; Interpersonal Relations; Ketamine; Life Change Events; N-Methyl-3,4-methylenedioxyamphetamine; Prazosin; Propranolol; Stress Disorders, Post-Traumatic; Stress, Psychological; User-Computer Interface | 2009 |
Single prolonged stress: toward an animal model of posttraumatic stress disorder.
Topics: Animals; Antidepressive Agents, Second-Generation; Antimetabolites; Arousal; Brain; Conditioning, Classical; Cycloserine; Disease Models, Animal; Extinction, Psychological; Fear; Glucocorticoids; Humans; Mental Recall; Paroxetine; Rats; Stress Disorders, Post-Traumatic | 2009 |
Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
Topics: Animals; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Eye Movement Desensitization Reprocessing; Humans; Hypnosis; Implosive Therapy; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic; Treatment Outcome | 2010 |
Psychosocial approaches of acute stress reactions.
Topics: Clinical Trials as Topic; Cognitive Behavioral Therapy; Conditioning, Classical; Crisis Intervention; Cycloserine; Disasters; Humans; Stress Disorders, Post-Traumatic; Treatment Outcome | 2005 |
16 trial(s) available for cycloserine and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Randomized controlled experimental study of hydrocortisone and D-cycloserine effects on fear extinction in PTSD.
Topics: Cycloserine; Double-Blind Method; Extinction, Psychological; Fear; Glucocorticoids; Humans; Hydrocortisone; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic | 2022 |
Enhancing exposure therapy for posttraumatic stress disorder (PTSD): a randomized clinical trial of virtual reality and imaginal exposure with a cognitive enhancer.
Topics: Brain-Derived Neurotrophic Factor; Cycloserine; Humans; Implosive Therapy; Nootropic Agents; Stress Disorders, Post-Traumatic; Treatment Outcome; Virtual Reality | 2022 |
Enhanced exposure therapy for combat-related Posttraumatic Stress Disorder (PTSD): Study protocol for a randomized controlled trial.
Topics: Combined Modality Therapy; Cycloserine; Humans; Implosive Therapy; Stress Disorders, Post-Traumatic; Veterans; Virtual Reality Exposure Therapy | 2019 |
The relationship between posttraumatic and depressive symptoms during virtual reality exposure therapy with a cognitive enhancer.
Topics: Adolescent; Adult; Aged; Cognition; Cycloserine; Depression; Female; Humans; Implosive Therapy; Male; Middle Aged; Nootropic Agents; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic; Survivors; Treatment Outcome; Virtual Reality Exposure Therapy; Young Adult | 2019 |
In session extinction and outcome in Virtual Reality Exposure Therapy for PTSD.
Topics: Adult; Alprazolam; Anxiety; Combined Modality Therapy; Cycloserine; Double-Blind Method; Extinction, Psychological; Female; Humans; Male; Stress Disorders, Post-Traumatic; Veterans; Virtual Reality Exposure Therapy; Young Adult | 2018 |
Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
Topics: Adult; Antimetabolites; Cycloserine; Female; Humans; Implosive Therapy; Male; Middle Aged; Personality Inventory; Predictive Value of Tests; Psychiatric Status Rating Scales; Self Report; Stress Disorders, Post-Traumatic; Time Factors | 2014 |
D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
Topics: Adult; Aged; Anger; Chemotherapy, Adjuvant; Chronic Disease; Cycloserine; Depression; Double-Blind Method; Extinction, Psychological; Fear; Female; Humans; Implosive Therapy; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Psychotropic Drugs; Sleep; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome | 2014 |
Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome | 2014 |
A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.
Topics: Adult; Afghan Campaign 2001-; Alprazolam; Anti-Anxiety Agents; Combined Modality Therapy; Cycloserine; Double-Blind Method; Extinction, Psychological; Female; Humans; Iraq War, 2003-2011; Male; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans; Virtual Reality Exposure Therapy | 2014 |
An investigation of outcome expectancies as a predictor of treatment response for combat veterans with PTSD: comparison of clinician, self-report, and biological measures.
Topics: Adult; Alprazolam; Combat Disorders; Combined Modality Therapy; Culture; Cycloserine; Female; Humans; Hydrocortisone; Implosive Therapy; Male; Middle Aged; Reflex, Startle; Self Report; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans; Virtual Reality Exposure Therapy | 2015 |
Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Double-Blind Method; Extinction, Psychological; Fear; Female; Humans; Implosive Therapy; Learning; Male; Self Report; Stress Disorders, Post-Traumatic; Treatment Outcome | 2015 |
Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy.
Topics: Adult; Alprazolam; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Galvanic Skin Response; Heart Rate; Humans; Hydrocortisone; Male; Photic Stimulation; Reference Values; Reflex, Startle; Saliva; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans; Virtual Reality Exposure Therapy; Young Adult | 2016 |
Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD.
Topics: Adult; Combined Modality Therapy; Cycloserine; Depression; Female; Humans; Implosive Therapy; Male; Middle Aged; Patient Satisfaction; Pilot Projects; Remote Consultation; Stress Disorders, Post-Traumatic; Treatment Outcome; Young Adult | 2017 |
A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
Topics: Adult; Antimetabolites; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Implosive Therapy; Male; Middle Aged; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic; Treatment Outcome | 2012 |
A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.
Topics: Adult; Chi-Square Distribution; Cycloserine; Double-Blind Method; Excitatory Amino Acid Agonists; Female; Humans; Implosive Therapy; Male; Psychiatric Status Rating Scales; Reproducibility of Results; Retrospective Studies; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Veterans | 2012 |
Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder.
Topics: Adult; Antibiotics, Antitubercular; Chronic Disease; Cognition; Cross-Over Studies; Cycloserine; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Receptors, Glycine; Stress Disorders, Post-Traumatic | 2002 |
14 other study(ies) available for cycloserine and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Shedding Light on the Transcriptomic Dark Matter in Biological Psychiatry: Role of Long Noncoding RNAs in D-cycloserine-Induced Fear Extinction in Posttraumatic Stress Disorder.
Topics: Animals; Computational Biology; Cycloserine; Disease Models, Animal; Disease Susceptibility; Emotions; Extinction, Psychological; Fear; Gene Expression Profiling; Gene Expression Regulation; Gene Ontology; Male; Mental Disorders; Quantitative Trait Loci; Rats; RNA, Long Noncoding; RNA, Messenger; Stress Disorders, Post-Traumatic; Transcriptome | 2020 |
The role of microRNAs in the therapeutic action of D-cycloserine in a post-traumatic stress disorder animal model: an exploratory study.
Topics: Animals; Anxiety; Anxiety Disorders; Conditioning, Classical; Cycloserine; Disease Models, Animal; Extinction, Psychological; Fear; High-Throughput Nucleotide Sequencing; Hippocampus; Male; Memory; MicroRNAs; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic | 2017 |
D-Cycloserine Facilitates Reversal in an Animal Model of Post-traumatic Stress Disorder.
Topics: Animals; Cycloserine; Discrimination, Psychological; Disease Models, Animal; Male; Mental Recall; Psychotropic Drugs; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reversal Learning; Stress Disorders, Post-Traumatic | 2018 |
Pharmacologic augmentation of extinction learning during exposure therapy for PTSD.
Topics: Alprazolam; Anti-Anxiety Agents; Cycloserine; Female; Humans; Male; Stress Disorders, Post-Traumatic; Veterans; Virtual Reality Exposure Therapy | 2014 |
The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
Topics: Animals; Brain; Cycloserine; Disease Models, Animal; Electroencephalography; Electroshock; Hydrocarbons, Halogenated; Male; Mice; Paroxetine; Receptors, Corticotropin-Releasing Hormone; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Wake Disorders; Stress Disorders, Post-Traumatic; Stress, Psychological; Thiazines; Wakefulness | 2015 |
PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Pressure; Cannabidiol; Clonidine; Cycloserine; Excitatory Amino Acid Agents; Extinction, Psychological; Fear; Male; Memory; Psychotropic Drugs; Random Allocation; Rats, Wistar; Stress Disorders, Post-Traumatic; Yohimbine | 2014 |
The impact of benzodiazepine management in the randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy.
Topics: Alprazolam; Anti-Anxiety Agents; Cycloserine; Female; Humans; Male; Stress Disorders, Post-Traumatic; Veterans; Virtual Reality Exposure Therapy | 2014 |
Response to Granoff.
Topics: Alprazolam; Anti-Anxiety Agents; Cycloserine; Female; Humans; Male; Stress Disorders, Post-Traumatic; Veterans; Virtual Reality Exposure Therapy | 2014 |
Possible negative effects of extinction learning on outcomes for patients receiving exposure therapy.
Topics: Alprazolam; Anti-Anxiety Agents; Cycloserine; Female; Humans; Male; Stress Disorders, Post-Traumatic; Veterans; Virtual Reality Exposure Therapy | 2014 |
Response to Smith.
Topics: Alprazolam; Anti-Anxiety Agents; Cycloserine; Female; Humans; Male; Stress Disorders, Post-Traumatic; Veterans; Virtual Reality Exposure Therapy | 2014 |
Enhancing cognitive behavioral therapy: Is the finish line in sight?
Topics: Anxiety; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Stress Disorders, Post-Traumatic | 2017 |
Erasing painful memories.
Topics: Animals; Behavior Therapy; Cycloserine; Extinction, Psychological; Fear; Humans; Memory; Memory, Long-Term; Memory, Short-Term; Reinforcement, Psychology; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic | 2012 |
Enhancing prolonged exposure therapy for posttraumatic stress disorder with D-cycloserine: further support for treatments that promote experience-dependent neuroplasticity.
Topics: Antimetabolites; Cycloserine; Female; Humans; Implosive Therapy; Male; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic | 2012 |
Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
Topics: Analysis of Variance; Animals; Antimetabolites; Behavior, Animal; Cycloserine; Disease Models, Animal; Electroshock; Extinction, Psychological; Fear; Gene Expression Regulation; Hippocampus; Male; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Stress Disorders, Post-Traumatic; Stress, Psychological | 2008 |